ARTICLE | Clinical News
Agennix Inc. regulatory update
March 8, 1999 8:00 AM UTC
Agennix received Indian Patent No. 177,650 covering the production of recombinant human lactoferrin, a protein that regulates tumor necrosis factor alpha, and lactoferrin polypeptides, including ferm...